Targeted Screening for Barrett's Esophagus and Esophageal Cancer: Post Hoc Analysis From the Randomized BEST3 Trial

Affiliations

• ¹ Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Electronic address: [email protected].
• ² King's College London Cancer Prevention Trials Unit, Cancer Prevention Group, School of Cancer & Pharmaceutical Sciences, King's College London, Innovation Hub, Guys Cancer Centre, Guy's Hospital, Great Maze Pond, United Kingdom.
• ³ Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom; School of Cancer & Pharmaceutical Sciences, King's College London, Innovation Hub, Guys Cancer Centre, Guy's Hospital, Great Maze Pond, London, United Kingdom.
• ⁴ Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
• ⁵ King's College London Cancer Prevention Trials Unit, Cancer Prevention Group, School of Cancer & Pharmaceutical Sciences, King's College London, Innovation Hub, Guys Cancer Centre, Guy's Hospital, Great Maze Pond, United Kingdom; Centre for Cancer Screening, Prevention, and Early Diagnosis, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom. Electronic address: [email protected].
• ⁶ Early Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, United Kingdom. Electronic address: [email protected].